BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Çamcı G, Oğuz S. Association between Parkinson's Disease and Helicobacter Pylori. J Clin Neurol 2016;12:147-50. [PMID: 26932258 DOI: 10.3988/jcn.2016.12.2.147] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Hitchings R, Kelly L. Predicting and Understanding the Human Microbiome's Impact on Pharmacology. Trends Pharmacol Sci 2019;40:495-505. [PMID: 31171383 DOI: 10.1016/j.tips.2019.04.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
2 Roy Sarkar S, Banerjee S. Gut microbiota in neurodegenerative disorders. Journal of Neuroimmunology 2019;328:98-104. [DOI: 10.1016/j.jneuroim.2019.01.004] [Cited by in Crossref: 90] [Cited by in F6Publishing: 80] [Article Influence: 30.0] [Reference Citation Analysis]
3 Verugina NI, Levin OS, Lyashenko EA. [The role of the gut microbiota in Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:86-91. [PMID: 34870920 DOI: 10.17116/jnevro202112110286] [Reference Citation Analysis]
4 Gonçalves AM, Pereira-Santos AR, Esteves AR, Cardoso SM, Empadinhas N. The Mitochondrial Ribosome: A World of Opportunities for Mitochondrial Dysfunction Toward Parkinson's Disease. Antioxid Redox Signal 2021;34:694-711. [PMID: 32098485 DOI: 10.1089/ars.2019.7997] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Riaz Rajoka MS, Zhao H, Li N, Lu Y, Lian Z, Shao D, Jin M, Li Q, Zhao L, Shi J. Origination, change, and modulation of geriatric disease-related gut microbiota during life. Appl Microbiol Biotechnol 2018;102:8275-89. [PMID: 30066188 DOI: 10.1007/s00253-018-9264-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
6 Kramer P. Mitochondria-Microbiota Interaction in Neurodegeneration. Front Aging Neurosci 2021;13:776936. [PMID: 35002678 DOI: 10.3389/fnagi.2021.776936] [Reference Citation Analysis]
7 Cryan JF, O'riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, Guzzetta KE, Jaggar M, Long-smith CM, Lyte JM, Martin JA, Molinero-perez A, Moloney G, Morelli E, Morillas E, O'connor R, Cruz-pereira JS, Peterson VL, Rea K, Ritz NL, Sherwin E, Spichak S, Teichman EM, van de Wouw M, Ventura-silva AP, Wallace-fitzsimons SE, Hyland N, Clarke G, Dinan TG. The Microbiota-Gut-Brain Axis. Physiological Reviews 2019;99:1877-2013. [DOI: 10.1152/physrev.00018.2018] [Cited by in Crossref: 551] [Cited by in F6Publishing: 492] [Article Influence: 183.7] [Reference Citation Analysis]
8 Drobny A, Ngo PA, Neurath MF, Zunke F, López-Posadas R. Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson's Disease. Front Med (Lausanne) 2021;8:655123. [PMID: 34368179 DOI: 10.3389/fmed.2021.655123] [Reference Citation Analysis]
9 Morais LH, Schreiber HL 4th, Mazmanian SK. The gut microbiota-brain axis in behaviour and brain disorders. Nat Rev Microbiol 2021;19:241-55. [PMID: 33093662 DOI: 10.1038/s41579-020-00460-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 27.5] [Reference Citation Analysis]
10 Sian-hülsmann J. Wilful pathogens provoke a gut feeling in Parkinson’s disease. J Neural Transm. [DOI: 10.1007/s00702-021-02448-3] [Reference Citation Analysis]
11 Parashar A, Udayabanu M. Gut microbiota: Implications in Parkinson's disease. Parkinsonism Relat Disord 2017;38:1-7. [PMID: 28202372 DOI: 10.1016/j.parkreldis.2017.02.002] [Cited by in Crossref: 102] [Cited by in F6Publishing: 86] [Article Influence: 20.4] [Reference Citation Analysis]
12 Anis E, Xie A, Brundin L, Brundin P. Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease. Trends Endocrinol Metab 2021:S1043-2760(21)00268-X. [PMID: 34949514 DOI: 10.1016/j.tem.2021.11.005] [Reference Citation Analysis]
13 Faruqui NA, Prium DH, Mowna SA, Ullah MA, Araf Y, Sarkar B, Zohora US, Rahman MS. Gut microorganisms and neurological disease perspectives. Future Neurology 2021;16:FNL53. [DOI: 10.2217/fnl-2020-0026] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zendehdel A, Roham M. Role of Helicobacter pylori infection in the manifestation of old age-related diseases. Mol Genet Genomic Med 2020;8:e1157. [PMID: 32067423 DOI: 10.1002/mgg3.1157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
15 Rani L, Mondal AC. Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications. Neurosci Res 2021;168:100-12. [PMID: 33417973 DOI: 10.1016/j.neures.2021.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Boeri L, Perottoni S, Izzo L, Giordano C, Albani D. Microbiota-Host Immunity Communication in Neurodegenerative Disorders: Bioengineering Challenges for In Vitro Modeling. Adv Healthc Mater 2021;10:e2002043. [PMID: 33661580 DOI: 10.1002/adhm.202002043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
17 Yang D, Zhao D, Shah SZA, Wu W, Lai M, Zhang X, Li J, Guan Z, Zhao H, Li W, Gao H, Zhou X, Yang L. Implications of gut microbiota dysbiosis and metabolic changes in prion disease. Neurobiol Dis 2020;135:104704. [PMID: 31837420 DOI: 10.1016/j.nbd.2019.104704] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
18 Liu J, Xu F, Nie Z, Shao L. Gut Microbiota Approach-A New Strategy to Treat Parkinson's Disease. Front Cell Infect Microbiol 2020;10:570658. [PMID: 33194809 DOI: 10.3389/fcimb.2020.570658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 de Korwin JD, Ianiro G, Gibiino G, Gasbarrini A. Helicobacter pylori infection and extragastric diseases in 2017. Helicobacter 2017;22 Suppl 1. [PMID: 28891133 DOI: 10.1111/hel.12411] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
20 Fried S, Wemelle E, Cani PD, Knauf C. Interactions between the microbiota and enteric nervous system during gut-brain disorders. Neuropharmacology 2021;197:108721. [PMID: 34274348 DOI: 10.1016/j.neuropharm.2021.108721] [Reference Citation Analysis]
21 Thangaleela S, Sivamaruthi BS, Kesika P, Bharathi M, Chaiyasut C. Role of the Gut–Brain Axis, Gut Microbial Composition, Diet, and Probiotic Intervention in Parkinson’s Disease. Microorganisms 2022;10:1544. [DOI: 10.3390/microorganisms10081544] [Reference Citation Analysis]
22 Fernández-Espejo E. Microorganisms that are related with increased risk for Parkinson's disease. Neurologia (Engl Ed) 2020:S0213-4853(20)30301-7. [PMID: 33160724 DOI: 10.1016/j.nrl.2020.08.020] [Reference Citation Analysis]
23 Fernández-espejo E. Microorganisms associated with increased risk of Parkinson’s disease. Neurología (English Edition) 2022. [DOI: 10.1016/j.nrleng.2020.08.023] [Reference Citation Analysis]
24 Freitas ME, Hess CW, Fox SH. Motor Complications of Dopaminergic Medications in Parkinson's Disease. Semin Neurol 2017;37:147-57. [PMID: 28511255 DOI: 10.1055/s-0037-1602423] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
25 Lolekha P, Sriphanom T, Vilaichone RK. Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson's disease patients: A prospective cohort study (HP-PD trial). PLoS One 2021;16:e0251042. [PMID: 33945559 DOI: 10.1371/journal.pone.0251042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Tan LY, Yeo XY, Bae HG, Lee DPS, Ho RC, Kim JE, Jo DG, Jung S. Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases? Life (Basel) 2021;11:698. [PMID: 34357070 DOI: 10.3390/life11070698] [Reference Citation Analysis]
27 Maev IV, Bakulin IG, Kurilovich SA, Bakulina NV, Andreev NG, Golubev NN. Helicobacter pylori and extragastroduodenal diseases: the proven facts and assumptions. Dok gastroenterol 2018;7:45. [DOI: 10.17116/dokgastro2018703145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Yemula N, Dietrich C, Dostal V, Hornberger M. Parkinson's Disease and the Gut: Symptoms, Nutrition, and Microbiota. J Parkinsons Dis 2021. [PMID: 34250955 DOI: 10.3233/JPD-212707] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Doroszkiewicz J, Groblewska M, Mroczko B. The Role of Gut Microbiota and Gut-Brain Interplay in Selected Diseases of the Central Nervous System. Int J Mol Sci 2021;22:10028. [PMID: 34576191 DOI: 10.3390/ijms221810028] [Reference Citation Analysis]
30 Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, Soleimanpour S. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders. Clin Microbiol Rev 2022;:e0033820. [PMID: 34985325 DOI: 10.1128/CMR.00338-20] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
31 Sherwin E, Dinan TG, Cryan JF. Recent developments in understanding the role of the gut microbiota in brain health and disease. Ann N Y Acad Sci 2018;1420:5-25. [PMID: 28768369 DOI: 10.1111/nyas.13416] [Cited by in Crossref: 110] [Cited by in F6Publishing: 94] [Article Influence: 22.0] [Reference Citation Analysis]
32 Chatterjee K, Banerjee S. Microbiome and motor neuron diseases. Prog Mol Biol Transl Sci 2020;176:111-22. [PMID: 33814112 DOI: 10.1016/bs.pmbts.2020.08.010] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Alfonsetti M, Castelli V, d'Angelo M. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease. Nutrients 2022;14:380. [PMID: 35057561 DOI: 10.3390/nu14020380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Vijiaratnam N, Foltynie T. Therapeutic Strategies to Treat or Prevent Off Episodes in Adults with Parkinson's Disease. Drugs 2020;80:775-96. [PMID: 32382948 DOI: 10.1007/s40265-020-01310-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
35 Unger MM, Becker A, Keller A, Schäfer KH, Schwiertz A, Oertel WH. [The role of the gut microbiome in idiopathic Parkinson's disease]. Nervenarzt 2020;91:1085-95. [PMID: 33025073 DOI: 10.1007/s00115-020-01011-x] [Reference Citation Analysis]
36 Dogra N, Mani RJ, Katare DP. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease. Cell Mol Neurobiol 2021. [PMID: 33649989 DOI: 10.1007/s10571-021-01066-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
37 McGee DJ, Lu XH, Disbrow EA. Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson's Disease. J Parkinsons Dis 2018;8:367-74. [PMID: 29966206 DOI: 10.3233/JPD-181327] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 9.7] [Reference Citation Analysis]
38 Huang HK, Wang JH, Lei WY, Chen CL, Chang CY, Liou LS. Helicobacter pylori infection is associated with an increased risk of Parkinson's disease: A population-based retrospective cohort study. Parkinsonism Relat Disord. 2018;47:26-31. [PMID: 29174171 DOI: 10.1016/j.parkreldis.2017.11.331] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
39 Chandra S, Alam MT, Dey J, Sasidharan BCP, Ray U, Srivastava AK, Gandhi S, Tripathi PP. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders. Curr Top Med Chem 2020;20:1142-53. [PMID: 32282304 DOI: 10.2174/1568026620666200413091101] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
40 Yang X, Qian Y, Xu S, Song Y, Xiao Q. Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson's Disease. Front Aging Neurosci 2017;9:441. [PMID: 29358918 DOI: 10.3389/fnagi.2017.00441] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 12.5] [Reference Citation Analysis]
41 Nair AT, Ramachandran V, Joghee NM, Antony S, Ramalingam G. Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review. J Neurogastroenterol Motil 2018;24:30-42. [PMID: 29291606 DOI: 10.5056/jnm17105] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 19.8] [Reference Citation Analysis]
42 Munoz-Pinto MF, Empadinhas N, Cardoso SM. The neuromicrobiology of Parkinson's disease: A unifying theory. Ageing Res Rev 2021;70:101396. [PMID: 34171417 DOI: 10.1016/j.arr.2021.101396] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
43 Kenna JE, Bakeberg MC, Gorecki AM, Chin Yen Tay A, Winter S, Mastaglia FL, Anderton RS. Characterization of Gastrointestinal Symptom Type and Severity in Parkinson's Disease: A Case-Control Study in an Australian Cohort. Mov Disord Clin Pract 2021;8:245-53. [PMID: 33553495 DOI: 10.1002/mdc3.13134] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Yang D, Zhao D, Ali Shah SZ, Wu W, Lai M, Zhang X, Li J, Guan Z, Zhao H, Li W, Gao H, Zhou X, Yang L. The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease. Front Neurol 2019;10:1155. [PMID: 31781020 DOI: 10.3389/fneur.2019.01155] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
45 Rajput C, Sarkar A, Sachan N, Rawat N, Singh MP. Is Gut Dysbiosis an Epicenter of Parkinson's Disease? Neurochem Res 2021;46:425-38. [PMID: 33400024 DOI: 10.1007/s11064-020-03187-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Fernández-Espejo E, Rodriguez de Fonseca F, Suárez J, Martín de Pablos Á. Cerebrospinal fluid lactoperoxidase level is enhanced in idiopathic Parkinson's disease, and correlates with levodopa equivalent daily dose. Brain Res 2021;1761:147411. [PMID: 33676939 DOI: 10.1016/j.brainres.2021.147411] [Reference Citation Analysis]
47 Lerner A, Matthias T; 1 B. Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. . AIMS Biophysics 2016;3:546-52. [DOI: 10.3934/biophy.2016.4.546] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
48 Rezvani F, Sayadnasiri M, Rezaei O. Restless legs syndrome in patients infected with Helicobacter pylori. Neurological Research 2018;40:583-7. [DOI: 10.1080/01616412.2018.1454704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
49 Hannachi N, Camoin-Jau L. Drug Response Diversity: A Hidden Bacterium? J Pers Med 2021;11:345. [PMID: 33922920 DOI: 10.3390/jpm11050345] [Reference Citation Analysis]
50 Fackrell R, Carroll CB, Grosset DG, Mohamed B, Reddy P, Parry M, Chaudhuri KR, Foltynie T. Noninvasive options for 'wearing-off' in Parkinson's disease: a clinical consensus from a panel of UK Parkinson's disease specialists. Neurodegener Dis Manag 2018;8:349-60. [PMID: 29975112 DOI: 10.2217/nmt-2018-0020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
51 Sun X, Xue L, Wang Z, Xie A. Update to the Treatment of Parkinson's Disease Based on the Gut-Brain Axis Mechanism. Front Neurosci 2022;16:878239. [PMID: 35873830 DOI: 10.3389/fnins.2022.878239] [Reference Citation Analysis]
52 Karpenko MN, Muruzheva ZM, Pestereva NS, Ekimova IV. An Infection Hypothesis of Parkinson’s Disease. Neurosci Behav Physi 2019;49:555-61. [DOI: 10.1007/s11055-019-00769-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
53 Hasby Saad M, Safwat O, El-Guindy D, Raafat R, Elgendy D, Hasby E. Biomolecular Changes and Cortical Neurodegenerative Lesions in Trichinella Spiralis Infected BALB/c Mice: A Preliminary Study Elucidating a Potential Relationship Between Systemic Helminthic Infections and Idiopathic Parkinson's. Helminthologia 2018;55:261-74. [PMID: 31662657 DOI: 10.2478/helm-2018-0029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Çam M, Kutluana U. Evaluation of upper endoscopic findings in patients with restless legs syndrome and gastric complaints. Arq Neuropsiquiatr 2020;78:217-23. [PMID: 32294750 DOI: 10.1590/0004-282X20190192] [Reference Citation Analysis]
55 Nyholm D, Hellström PM. Effects of Helicobacter pylori on Levodopa Pharmacokinetics. J Parkinsons Dis 2021;11:61-9. [PMID: 33164946 DOI: 10.3233/JPD-202298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]